You have access
Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial
KOICHI MITSUYA, YASUTO AKIYAMA, AKIRA IIZUKA, HARUO MIYATA, SHOICHI DEGUCHI, NAKAMASA HAYASHI, CHIE MAEDA, RYOTA KONDOU, AKARI KANEMATSU, KYOKO WATANABE, TADASHI ASHIZAWA, YOSHIAKI ABE, ICHIRO ITO, TAKUMA OISHI, TAKASHI SUGINO, YOKO NAKASU and KEN YAMAGUCHI
Anticancer Research November 2020, 40 (11) 6473-6484; DOI: https://doi.org/10.21873/anticanres.14669